US biotech Xoma has decided to rely on a contract manufacturing organisation for its Phase III and commercial production needs, …
Researchers in the US have developed a new drug delivery system based on silk, which could allow drugs and vaccines …
Angry investors in US generic drugmaker Hospira have filed a class action lawsuit against the company, alleging that it misled …
Akzo Nobel has been taken to task by the US FDA for manufacturing standards at one of its active pharmaceutical …
Boehringer Ingelheim plans to invest €50 million in its manufacturing plant in Shanghai as part of a drive to increase …

The US Environmental Protection Agency is due to deliver a verdict on a $205 million proposal by Pfizer to clean …

GlaxoSmithKline took a step closer to becoming a generator of electricity in a bid to offset the high energy demands …

Roche has officially opened a 250 million Swiss franc ($271m) R&D centre in Switzerland that will be used to develop …
Regulatory authorities around the world are recalling cancer drugs manufactured by Boehringer Ingelheim’s Ben Venue Laboratories subsidiary after an inspection …

Belgian pharmaceutical company UCB showcased its new bioproduction facility in Bulle, Switzerland, yesterday, saying that the workforce there looks set …
A joint venture set up by GlaxoSmithKline and Pfizer is planning to start manufacturing in Russia thanks to a partnership …
France’s Flamel Technologies has won a long-term contract from GlaxoSmithKline focusing on the production of the drugmaker’s Coreg CR heart …
Includes a formulation problem for Teva, facility updates from Taro and ADM, and a new excipient screening initiative at the …

Swiss contract manufacturer and fine chemicals company Lonza has said it plans to expand its biopharmaceutical production unit in Slough, …
Gene therapy specialist Oxford BioMedica has said it plans to acquire a £1.9 million ($3.1m) manufacturing facility from contract manufacturer …